With MPs discussing the condition in Parliament this week, COVER investigates what advisers should be aware of when discussing diabetes with clients
While the idea of a diabetes debate in Parliament this week may seem a tad pointless with Brexit discussions still up in the air, it is not an issue we can afford to ignore - both in society and as an industry. Questions might remain around supplies of insulin in the UK post-EU, but another is the extent to which the protection and health industry can extend itself to provide better access to insurance to people suffering from type 1 and type 2 diabetes. Access Life cover is currently available...
From ‘money takers’ to ‘health helpers’?
At The HAC, London
'Client barriers are only half the battle'
Asks Alan Lakey
From PPI to the credit crunch